Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERTAPENEM vs ERYTHROMYCIN ETHYLSUCCINATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERTAPENEM vs ERYTHROMYCIN ETHYLSUCCINATE: Safety Overview

Metric ERTAPENEM ERYTHROMYCIN ETHYLSUCCINATE
Total FAERS Reports 4,069 258
Deaths Reported 223 8
Death Rate 5.5% 3.1%
Hospitalizations 1,617 47
Average Patient Age 64.1 yrs 39.1 yrs
% Female Patients 54.5% 73.9%
FDA Approval Date Apr 16, 2018 Approved Prior to Jan 1, 1982
Manufacturer Merck Sharp & Dohme LLC Azurity Pharmaceuticals, Inc. (former...
Route INTRAMUSCULAR ORAL
Marketing Status Prescription Prescription